Introduction

Respiratory syncytial virus (RSV) is a common and highly contagious virus that primarily affects the respiratory tract. RSV is extremely common in young children, and nearly all children contract the virus by the age of two.¹

While most children recover from RSV within a week or two, the virus can cause severe respiratory illness, particularly in children or infants with underlying health conditions. Understanding whether RSV can lead to chronic respiratory illnesses in adolescents is crucial for developing effective long-term healthcare strategies.

Understanding RSV

RSV is a common cause of respiratory illness in young children. The virus spreads through droplets, which are released into the air when an infected person coughs or sneezes. Common symptoms of RSV infection include a runny nose, coughing, wheezing, and fever.¹ In severe cases, RSV can lead to bronchiolitis and pneumonia and require hospitalisation. Infants, premature babies, and children with weakened immune systems or congenital heart disease are at a higher risk of severe RSV infections.¹

In its acute phase, RSV can cause mild cold-like symptoms. However, in severe cases, it can cause a significant lower respiratory tract infection, leading to bronchiolitis. Bronchiolitis is characterised by inflammation and congestion in the small airways (bronchioles) of the lung.¹ This condition can be particularly dangerous in infants, leading to difficulty breathing and requiring hospitalisation.

Acute impact of RSV

During an acute RSV infection, children might experience symptoms that range from mild upper respiratory tract infections (such as rhinitis) to severe lower respiratory tract infections. These severe cases might require hospital-based treatments such as oxygen supplementation, intravenous fluids, and in some instances, mechanical ventilation.² Antiviral medications are not commonly used, as there is no specific cure for RSV. The primary aim during the acute phase is to maintain adequate oxygenation and hydration.

Most children recover fully, but the severity of the initial infection can influence long-term outcomes.

Chronic respiratory illness

Chronic respiratory illnesses are long-term conditions that affect the airways and other parts of the lungs. Examples include asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). These conditions can lead to persistent breathing difficulties, frequent respiratory infections, and reduced quality of life. Risk factors for chronic respiratory illnesses include genetic predisposition, environmental exposures (such as tobacco smoke and air pollution), and severe respiratory infections in early childhood.³

Asthma is one of the most common chronic respiratory conditions that may follow a severe RSV infection. Asthma involves chronic inflammation of the airways, causing episodes of wheezing, shortness of breath, chest tightness, and coughing. Chronic bronchitis, characterised by a persistent cough and mucus production, and COPD, which includes chronic bronchitis and emphysema, can also develop from ongoing respiratory issues stemming from childhood infections.

The link between RSV and chronic respiratory illnesses

Research suggests that there is a link between severe RSV infections in early childhood and the development of chronic respiratory illnesses in later life. Studies have shown that children who experience severe RSV bronchiolitis are at an increased risk of developing asthma and other chronic respiratory conditions during adolescence. The mechanisms underlying this link are not fully understood, but it is believed that severe RSV infection may cause long-lasting changes in the airways, such as increased airway hyperreactivity and inflammation.⁴

Several longitudinal studies have followed children from infancy into adolescence to assess the long-term impact of severe RSV infections. For instance, a study published in the American Journal of Respiratory and Critical Care Medicine tracked 1,200 children from birth until adolescence, and found that children hospitalised with RSV bronchiolitis were more likely to develop asthma by the age of 13.⁵ Another study published in the Journal of Allergy and Clinical Immunology reported that RSV infection in infancy was associated with increased airway responsiveness and reduced lung function in later childhood.⁶ These findings underscore the importance of monitoring and managing the respiratory health of children with a history of severe RSV.

The proposed mechanisms linking RSV to chronic respiratory conditions include persistent inflammation and structural changes in the airway. Indeed, severe RSV infection can trigger overactive immune responses, causing lasting damage to the lung tissue and airways. This damage can make the airways more sensitive to other environmental triggers, such as allergens and pollutants, increasing the likelihood of chronic conditions like asthma.⁷

Genetic and environmental factors also play a role in this link. These factors can interact in complex ways, making it challenging to isolate the direct impact of RSV from other contributing elements.

Current guidelines and recommendations

Medical guidelines from organisations such as the National Institute for Health and Care Excellence (NICE) and the British Medical Journal (BMJ) emphasise the importance of preventive measures, early intervention, and long-term monitoring for children at high risk of severe RSV infection. 

Preventive strategies are vital in reducing the incidence and severity of RSV infections. Maintaining good hygiene, avoiding close contact with infected individuals, and maintaining clean environments are basic but effective measures. For high-risk infants, such as those born prematurely or with congenital heart or lung disease, the administration of palivizumab during the RSV season can significantly reduce the risk of severe disease.

Early interventions focus on prompt treatment of acute RSV infections to minimise the risk of complications. Long-term monitoring includes regular follow-ups for children who have experienced severe RSV infection to detect and manage any emerging chronic respiratory conditions. Guidelines recommend that healthcare providers educate parents about the signs of chronic respiratory illnesses and the importance of avoiding environmental risk factors.

Clinical observations also highlight the importance of early and ongoing respiratory care for children affected by severe RSV. Paediatricians and pulmonologists have reported cases where early intervention and consistent follow-up have helped manage and mitigate the progression of chronic respiratory conditions. These observations underscore the need for comprehensive management strategies that address both the immediate and long-term impacts of RSV.

Summary

There is evidence to suggest that severe RSV infections in early childhood can lead to chronic respiratory illnesses in adolescents, highlighting the importance of preventive measures, early treatment, and long-term monitoring for children at high risk of RSV. Healthcare providers and parents should be aware of the potential long-term effects of RSV and work together to minimise risk factors and ensure optimal respiratory health outcomes. Further research is essential to fully understand the mechanisms linking RSV to chronic respiratory conditions and to develop more effective management strategies.

By adhering to current medical guidelines and staying informed about the latest research, healthcare professionals can better manage the acute and long-term impacts of RSV. Parents can play a crucial role by recognising early signs of respiratory distress and seeking timely medical intervention. Through a combined effort, it is possible to reduce the burden of chronic respiratory illnesses associated with RSV, ensuring healthier futures for children affected by this common virus.